Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells
causes memory loss and cognitive decline. Existing drugs only suppress symptoms or delay …

The potential of nanotechnology in advancing the diagnosis and treatment of
neurodegenerative diseases is explored in this comprehensive literature review. The …

Neurodegenerative disorders are common among aging populations around the globe.
Most are characterized by loss of neurons, protein aggregates, oxidative stress …

Multifunctional nanocarriers are increasingly promising for disease treatment aimed to
regulate multiple pathological dysfunctions and overcome barriers in drug delivery. Here we …

Effective treatment of brain disorders remains a tough task in medical science. Age-old brain
disorders like Parkinson's (PD) and Alzheimer's (AD) are yet to be managed effectively in …

Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related
disorders featured by progressive impairment of motor and/or cognitive functions, often …

Alzheimer's disease is a neurological disorder that results in cognitive and behavioral
impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs …

Alzheimer disease (AD) is very common among the older people. There are few medications
available as oral and suspension dosage forms for the management of AD. Due to the rising …

Alzheimer's disease (AD), a progressively fatal neurodegenerative disorder, is the most
prominent form of dementia found today. Patients suffering from Alzheimer's begin to show …